D-tek

D-tek S.A. is a Belgian company specialized in the development, manufacturing and commercialization of innovative in vitro diagnostic (IVD) solutions for human autoimmune diseases.

With more than 30 years of experience in autoimmunity, D-tek has built strong expertise in the development of diagnostic assays and dedicated instrumentation for the detection and identification of autoantibodies. The company combines scientific expertise, R&D, manufacturing, quality and regulatory capabilities within its activities in Belgium.

D-tek’s portfolio includes a broad range of solutions for the diagnosis of systemic and organ-specific autoimmune diseases. A key strength of the company is its expertise in multiplex diagnostics, allowing several biomarkers to be investigated simultaneously while maintaining their individual identification. This approach provides laboratories with comprehensive diagnostic information from a single test and supports efficient autoimmune testing workflows.

D-tek develops and manufactures both diagnostic kits and dedicated instruments, enabling the company to provide integrated solutions to clinical laboratories. Its technologies are designed with particular attention to reliability, ease of use, workflow efficiency and the evolving needs of diagnostic laboratories.

Innovation is at the heart of D-tek’s strategy. The company continuously invests in research and development, new biomarkers, assay development, automation and multiplex technologies, with the objective of continuously improving its diagnostic solutions and addressing emerging clinical and laboratory needs.

D-tek actively seeks scientific and technological collaborations with universities, research centers, laboratories and industrial partners. Such partnerships can range from biomarker evaluation and assay development to technology integration, proof-of-concept studies and the co-development of new diagnostic solutions.

The company operates under an ISO 13485 quality management system and has made major investments to ensure the compliance of its diagnostic kits and instruments with the European In Vitro Diagnostic Regulation (IVDR). Regulatory expertise and product quality are therefore integral parts of D-tek’s development and commercialization strategy.

From its Belgian base, D-tek serves an international market through a network of specialized distributors and continues to expand its presence in Europe and other international markets. The company is interested in establishing new partnerships with distributors that have strong knowledge of their local IVD markets and clinical laboratory networks.

As a focused and independent diagnostic company, D-tek combines the flexibility and responsiveness of an SME with decades of specialized expertise in autoimmunity. Its ambition is to continue developing innovative, clinically relevant and efficient diagnostic solutions while building long-term relationships with distributors, technology companies, researchers and other partners worldwide.

At MEDICA, D-tek is particularly interested in meeting international distributors, IVD companies, technology providers, universities, research organizations and laboratories to explore distribution agreements, technological and scientific collaborations, R&D projects, OEM/private-label opportunities and the co-development of innovative diagnostic solutions.